CAROTECH BHD
KLSE (MYR): CAROTEC (0076)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.02
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Financial
Market Cap
Market Cap
0 Million
NOSH
911 Million
Latest Quarter
Latest Quarter
31-Dec-2011 [#2]
Announcement Date
20-Feb-2012
Next Quarter
31-Mar-2012
Est. Ann. Date
01-Jun-2012
Est. Ann. Due Date
30-May-2012
QoQ | YoY
50.63% | 23.05%
T4Q Result
Revenue | NP to SH
50,164.000 | -40,315.000
RPS | P/RPS
5.51 Cent | 0.00
EPS | P/E | EY
-4.43 Cent | 0.00 | 0.00%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.01 | 0.00
QoQ | YoY
5.62% | 60.4%
NP Margin | ROE
-80.37% | -885.27%
F.Y. | Ann. Date
31-Dec-2011 | 20-Feb-2012
Latest Audited Result
Latest Audited Result
30-Jun-2011
Announcement Date
10-Nov-2011
Next Audited Result
30-Jun-2012
Est. Ann. Date
10-Nov-2012
Est. Ann. Due Date
27-Dec-2012
Annual (Unaudited)
Revenue | NP to SH
40,010.000 | -23,695.000
RPS | P/RPS
4.39 Cent | 0.00
EPS | P/E | EY
-2.60 Cent | 0.00 | 0.00%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.02 | 0.00
YoY
74.38%
NP Margin | ROE
-59.22% | -113.04%
F.Y. | Ann. Date
30-Jun-2011 | 29-Aug-2011
Annualized Result
Revenue | NP to SH
61,948.000 | -48,496.000
RPS | P/RPS
6.80 Cent | 0.00
EPS | P/E | EY
-5.32 Cent | 0.00 | 0.00%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
25.31% | -217.92%
NP Margin | ROE
-78.29% | -1,064.00%
F.Y. | Ann. Date
31-Dec-2011 | 20-Feb-2012
Business Process
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 3 / 4 | 75.00% | 3 / 8 | 37.50% |
| Total Positive Profit Years | 0 / 4 | 0.00% | 2 / 8 | 25.00% |
| Continuous Quarters Of Positive Profit | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Average ROE | -94.88% | -60.54% | ||
| Average Net Profit Margin | -86.74% | -75.30% | ||
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Quarters Of Revenue Growth | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
| Total Positive Profit Years | 2 / 5 | 40.00% | 4 / 8 | 50.00% |
| Continuous Quarters Of Positive Profit | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Profit Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
| Total Dividend Years | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Dividend | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
| Average ROE | -73.01% | -41.83% | ||
| Average Net Profit Margin | -16.89% | -6.33% | ||
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 50,164 | 61,948 | 40,010 | 91,733 | 123,983 |
| NP to SH | -40,315 | -48,496 | -23,695 | -11,177 | -21,785 |
| Dividend | 0 | 0 | 0 | 427 | 683 |
| Adjusted EPS | -4.43 | -5.32 | -2.60 | -1.23 | -2.39 |
| Adjusted DPS | 0.00 | 0.00 | 0.00 | 0.05 | 0.08 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | 38.48% | 72.93% | 48.77% | 43.42% | -28.06% |
| NP to Owner | 50.63% | 23.05% | -217.92% | 20.48% | 54.88% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | 50.63% | 23.05% | -217.92% | 20.48% | 54.88% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.38% | -59.54% | -45.32% | 54.83% | -50.04% | -32.47% | -83.54% | -67.73% | -56.38% |
| NP to Owner | -70.14% | -85.06% | -260.69% | -104.67% | -122.61% | -333.88% | 74.38% | -8.77% | -111.99% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | -70.28% | -85.21% | -260.99% | -104.67% | -122.61% | -333.88% | 74.38% | -8.77% | -111.99% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Discussions
3 people like this. Showing 17 of 17 comments
recently there was an article interviewing the MD and he was saying that they hv a lot of interested buyers in their business a world producer in bio fuel.hovid too affected bcos shareholders given carotech shares as dividend
2012-03-30 11:21
From my past experience they will always give good views before the due, and might unload theirs,My experience: MEMS, MTONE, PAXELNT, KIMBLE
2012-03-30 11:48
most recent maxbiz.my advise of another potential delisting is IE-screwed up ctr shud hv been delisted long ago
2012-03-30 11:50
One doctor shared with me that they produce very goo Vitamin E. Dont't know why the stock is suffering losses
2012-03-30 21:31
Carotec owe people alot of money la. Their research failed.
Bro Raymond - the Vitamin E stuff I agreed with you. But the research
project using Oil Palm is burning MR HO. and now....
Carotec owes TAIKO @ BATU KAWAN - so now look at KLK and Batu Kawan shares.....their shares BERPULUH-PULUH RINGGIT LO.
2012-03-30 21:59
Bear in mind the counter is on the way for @de-listing@ which is beyond their control , you either can run now or drop your pant & run like headless chicken in coming days , ha ha
2012-04-01 10:01
Carotec is in the process of being wound up. I am wondering what the highly anticipated FDA trials would mean since the patent belongs to Carotech?
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=carotech&FIELD1=&co1=AND&TERM2=&FIELD2=&d=PTXT
2015-04-14 14:55
Post a Comment
Featured Posts
Apps
Top Articles
1
Nuclearinvestment
2
3
RHB Investment Research Reports
Technology, Property, and Construction - Penang- Silicon Hub of ASEAN
4
Follow Kim's Stockwatch!
THIS ANOTHER GEMS READY TO SKYROCKET!!! - MAJOR DEVELOPER IN PENANG
5
6
THE INVESTMENT APPROACH OF CALVIN TAN
CALVIN TAN SAY, THANK YOU 9 MILLION TIMES FOR 9 MILLION PAGE VIEWS IN i3 INVESTORS' FORUM!
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
tcgien
this counter can play contra, intraday , but at 0.04, sell 0.045. make 10% profit :p
2012-03-06 18:42